Novo Nordisk | NVO - Ebitda





Ebitda Perubahan Tanggal
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Bausch Health Companies USD 837M 94M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Merck USD 6.3B 2.09B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.3B 530M 2026-03
Novo Nordisk DKK 34.72B 2.57B 2026-03
Novo Nordisk DKK 31.44B 6.84B 2025-09
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Sanofi EUR 3.31B 3.65B 2026-03
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Zoetis USD 939M 101M 2025-12